In the quest for relief from the burdens of cancer treatment, individuals often turn to cannabis, seeking answers amidst the chaos of symptoms.
Recently, the Department of Health and Human Services recommended that cannabis be reclassified from a Schedule I Controlled Substance to a Schedule III Controlled Substance under the federal Controlled Substances Act. In a PM360 article Rescheduling Cannabis to a Schedule III Controlled Substance: A Regulator’s Perspective,
As more states legalize the use of cannabis, it can be challenging for employers to keep up and find reliable information. A recent Benefits Pro article, Employees are more likely to apply for jobs that offer cannabis benefits, shares findings from an EO Care ...
1 in 2 people will get cancer in their lifetime, and 40% of cancer patients use cannabis for treatment of symptoms. But clinical guidance for cannabis is difficult to find. That’s why Imerman Angels is partnering with EO Care — the first clinically guided cannabis health and wellness solution for employers, payers, and associations — to provide cannabis care and advice to members. ImermanAngels.org visitors will be able to access educational content including whether cannabis is right for them, how to optimize use, and even how to reduce use.
Ethan Zohn truly embodies the word “survivor.” In 2001, he won Survivor Africa, the third season of the popular reality TV show — and later became a two-time survivor of a rare blood cancer. At the age of 35 and in the prime of his life, this fit, former professional soccer player was diagnosed with CD20+ Hodgkin’s Lymphoma. Over several years, Ethan endured aggressive treatment including two stem cell transplants.
40% of cancer patients use cannabis to help the treatment of symptoms. But many are going it alone without clinical guidance, which can be ineffective and even unsafe. That’s why non-profit cancer survivor and caregiver support community Twist Out Cancer is partnering with EO Care...
EBN Talks with Bill Van Faasen, former chairman and CEO of Blue Cross Blue Shield Massachusetts and EO Care board member
On August 30, 2023, after a scientific/clinical review the US Department of Health and Human Services (HHS) acknowledged that cannabis has medicinal uses and recommended rescheduling cannabis to a Class 3 drug
In a recent Benefits Pro article What employers need to know about "guided use" of cannabis by Dr. Brooke Worster, an Associate Professor of Medicine at Jefferson Health in Philadelphia, PA, the Director of the Division of Supportive Oncology, and the Program Director of Cannabis Medicine for the Science and Business Master’s Program...
As employers continue to navigate the evolving dynamics of employee cannabis use, Human Resource Executive spoke with Dr. Brooke Worster, an Associate Professor of Medicine at Jefferson Health in Philadelphia, PA, the Director of the Division of Supportive Oncology...
eo Care in partnership with HR.com hosted an Employee Cannabis Use – Prevalence, Implications & Solutions webinar for HR professionals where we reviewed the prevalence of cannabis being at an all-time high, the risks of unguided use, and the benefits of employers offering health & wellness support in the form of clinically guided essential cannabis guidance for critical illnesses such as cancer, as well as symptom support, such as pain management, anxiety, and sleeplessness; resulting in improved workforce health, job satisfaction, and increased productivity.
The lack of pain relief combined with the risk of dangerous side effects, including death, has led to a need for alternative options to help treat chronic pain. Recently, there has been growing interest in the possibility that cannabis may be useful in combination or as a substitute for opioids in people with chronic pain.
Recent evidence suggests that using medical cannabis in combination with opioids to treat chronic pain may provide better treatment of pain and allow for a lower dose of opioids. It is important we find other tools that can be used to help improve the treatment of pain while keeping patients safe.
Despite conflicting evidence, for many patients with chronic pain, the risk of using opioids may be greater than the benefits, especially over long periods of time. It is important that patients wishing to understand the potential benefits and risks of using cannabis in addition to opioids discuss this with their health care provider prior to use.
Recent studies have shown patients using cannabis combined with opioids may be able to use a lower opioid dose or stop using opioids while still getting pain relief. This can help improve a patient's quality of life while also reducing the risk of serious side effects or death associated with opioids.
If you are someone using high doses of opioids and not getting adequate pain relief, or you're experiencing unwanted side effects, speaking to your health care provider about a trial of medical cannabis may be an option. Medical cannabis is not right for everyone, just as other medications may not be right for everyone.
Studies have shown low doses of cannabis may allow for lower doses of opioids to be used, leading to reduced side effects, improved symptoms and improved quality of life. Therefore, the combined use of cannabis and opioids may be a viable option for treating chronic pain in some individuals.
Inhaled cannabis can be useful for managing acute symptoms of chronic pain, but it should be vaporized to avoid respiratory harms associated with smoking. Vaporizing cannabis flower is also cheaper than cannabis oils, as dried flower is the cheapest form of product.
We recently discussed a study in which we found smoking cannabis was popular within a sample of medical cannabis dispensary users. We found smoking cannabis was associated with greater cannabis use and preference for THC-dominant chemovars and was associated with concurrent alcohol use disorder. These findings provided several key insights into risks and harm reduction strategies for people smoking cannabis with a medical intent.
This is the first part of a two-part series on a recent examination of the cannabis-use profiles and risk-factors associated with smoking cannabis in people using cannabis with medical intent. Smoking cannabis is associated with exposure to harmful toxins and therefore is one of the greatest health risks related to cannabis use. This is an important consideration for people using cannabis with a medical intent. Therefore, we examined the differences in those who prefer smoking cannabis to other consumption forms for mental health.Â
BOSTON, Aug. 17, 2022 (GLOBE NEWSWIRE) -- EO Care, Inc. ("EO" or "The Company"), a digital health company focused on cannabinoid-based treatments, announced the launch of a new, HIPAA-compliant service and technology platform to meet the need for scalable, affordable, data-informed cannabis care with ongoing clinical oversight.
In the Cannabis Care, Enabled club, eo hosts weekly discussions of medical and wellness cannabis. From our relationships with one another, to novel viruses, to cutting-edge technology; cannabis can effect many areas of our lives. The goal of our audio-only Clubhouse discussions is to foster a community of responsible cannabis users, educators, and advocates on Clubhouse. Visit the link below to join the conversation.
In 2018, my father was diagnosed with stage IV bladder cancer. Anyone with a loved one who has received a cancer diagnosis understands how the world instantly flips on its head. In the weeks following Dad’s diagnosis, our lives all totally changed. One priority overtook all others: easing Dad’s pain. Opioids were fraught with side effects, so we turned to cannabis.
Cannabis is illegal in the United States, but there are two dispensaries in my town. Cannabis is legal in my state, but I can’t consume it in public or bring it one state over.
In dealing with pain, finding and curing the underlying cause is the most effective approach. However, since the cause can be extremely difficult to identify, patients are sometimes left only with the option of managing their pain. For chronic pain sufferers, it is hard to identify a clear path to relief.
Chronic pain is prevalent. A 2016 report estimates that over 20% of adults in the United States have experienced some form of chronic pain. Of those 50 million Americans, 8% suffer from some form of high impact chronic pain; pain that has lasted over three months and prohibits them from performing important activities in their daily lives.
People are suffering. Cannabis offers the potential of relief, but cannabis care today leaves much to be desired in the way of guidance, data, and consistency. eo is a digital therapeutic, telemedicine platform and clinical data source. We are on a mission to deliver the future of cannabis care through personalized, calendar-based care plans and ongoing clinical guidance delivered on an intuitive digital platform.
Not all patients are the same. Each person has unique underlying health conditions, personal experiences, and needs. What works for one patient is not guaranteed to work for all. Some patients might be allergic to a specific medication, others might be able to tolerate it but are unable to take it due to incompatible work schedules, and others might be a perfect fit for the same medication.
The right community will grant you the ability to talk about shared experiences, educate yourself from a collective pool of knowledge, and bask in the comfort of knowing that you are not alone. There are communities of support for people who are battling cancer and coping with insomnia, so why shouldn’t there be a place for cannabis patients to gather and enjoy the benefits of community?
Last week, you took an edible to help manage your anxiety after a long work day. The cannabis provided some relief, but since then you haven’t been able to recreate that result. Starting your cannabis journey is daunting, and it can be hard to know where to go for guidance.
Cannabidiol (CBD) is a component of the plant cannabis with great potential for medical applications because of its proven anti-inflammatory, anti-tumoral, analgesic (pain-relieving), and anxiolytic (anxiety-relieving) properties and its lack of psychological side effects.
Proponents of cannabis use in a medical context have often suggested that it is a superior substitute of opioid for chronic pain management. Cannabis owes its analgesic properties to components called cannabinoids, with the two most prominent being cannabidiol (CBD) and tetrahydrocannabinol (THC). Both compounds have similar potential for treating chronic pain, however, while THC is addictive, CBD is not and therefore is of special clinical interest.
If you are having trouble getting a good night’s sleep these days, you’re not alone. Up to 70 million people are affected by sleep disorders, according to data from the National Institutes of Health, and consumers are spending $70 billion a year on sleep aids, 65% of which goes to medications.
Researchers recently identified a signaling pathway in the endocannabinoid system that regulates long-lasting anxiety, a central symptom of post-traumatic stress disorder (PTSD). In particular, CB2 - one of the two main endocannabinoid receptors - mediates the response: its activation appears to have an anxiolytic (anxiety reducing) effect while its inhibition an anxiogenic (anxiety inducing) one.
Researchers have recently analyzed popular vaping behavior and revealed the advantages of vaporizing medical cannabis. The general advantages of vaporizing medical cannabis include portability, concealability, and efficiency, while the medical advantages like promoting tobacco cessation and it’s quick-acting effects.
Along with THC, the cannabis plant produces over 400 different chemical compounds that include dozens of other cannabinoids like CBD and CBN, and hundreds terpenes like pinene, linalool and myrcene. When the compounds are applied together (whether it’s through smoking, vaping or especially transdermal applications), they work to provide unique effects and benefits.
In honor of Men's Health Month, tonight's webinar will focus on the unique differences that men may have when consuming cannabis.Join Dr. Caplan this evening to review the latest cannabis studies that relate to men's sexual, mental and physical health. All are welcome to attend and share their experiences, or to simply listen and learn.
A recent meta-analysis has found that cannabis is an effective treatment for those dealing with chronic pain. Researchers analyzed studies that compared cannabinoid-based therapies to placebos, concluding that those therapies served as an effective replacement or adjunctive therapy for more common pain relievers, such as opioids.
In the quest for relief from the burdens of cancer treatment, individuals often turn to cannabis, seeking answers amidst the chaos of symptoms.
Recently, the Department of Health and Human Services recommended that cannabis be reclassified from a Schedule I Controlled Substance to a Schedule III Controlled Substance under the federal Controlled Substances Act. In a PM360 article Rescheduling Cannabis to a Schedule III Controlled Substance: A Regulator’s Perspective,
As more states legalize the use of cannabis, it can be challenging for employers to keep up and find reliable information. A recent Benefits Pro article, Employees are more likely to apply for jobs that offer cannabis benefits, shares findings from an EO Care ...
1 in 2 people will get cancer in their lifetime, and 40% of cancer patients use cannabis for treatment of symptoms. But clinical guidance for cannabis is difficult to find. That’s why Imerman Angels is partnering with EO Care — the first clinically guided cannabis health and wellness solution for employers, payers, and associations — to provide cannabis care and advice to members. ImermanAngels.org visitors will be able to access educational content including whether cannabis is right for them, how to optimize use, and even how to reduce use.
Ethan Zohn truly embodies the word “survivor.” In 2001, he won Survivor Africa, the third season of the popular reality TV show — and later became a two-time survivor of a rare blood cancer. At the age of 35 and in the prime of his life, this fit, former professional soccer player was diagnosed with CD20+ Hodgkin’s Lymphoma. Over several years, Ethan endured aggressive treatment including two stem cell transplants.
40% of cancer patients use cannabis to help the treatment of symptoms. But many are going it alone without clinical guidance, which can be ineffective and even unsafe. That’s why non-profit cancer survivor and caregiver support community Twist Out Cancer is partnering with EO Care...
EBN Talks with Bill Van Faasen, former chairman and CEO of Blue Cross Blue Shield Massachusetts and EO Care board member
On August 30, 2023, after a scientific/clinical review the US Department of Health and Human Services (HHS) acknowledged that cannabis has medicinal uses and recommended rescheduling cannabis to a Class 3 drug
In a recent Benefits Pro article What employers need to know about "guided use" of cannabis by Dr. Brooke Worster, an Associate Professor of Medicine at Jefferson Health in Philadelphia, PA, the Director of the Division of Supportive Oncology, and the Program Director of Cannabis Medicine for the Science and Business Master’s Program...
As employers continue to navigate the evolving dynamics of employee cannabis use, Human Resource Executive spoke with Dr. Brooke Worster, an Associate Professor of Medicine at Jefferson Health in Philadelphia, PA, the Director of the Division of Supportive Oncology...
eo Care in partnership with HR.com hosted an Employee Cannabis Use – Prevalence, Implications & Solutions webinar for HR professionals where we reviewed the prevalence of cannabis being at an all-time high, the risks of unguided use, and the benefits of employers offering health & wellness support in the form of clinically guided essential cannabis guidance for critical illnesses such as cancer, as well as symptom support, such as pain management, anxiety, and sleeplessness; resulting in improved workforce health, job satisfaction, and increased productivity.
In 2018, my father was diagnosed with stage IV bladder cancer. Anyone with a loved one who has received a cancer diagnosis understands how the world instantly flips on its head. In the weeks following Dad’s diagnosis, our lives all totally changed. One priority overtook all others: easing Dad’s pain. Opioids were fraught with side effects, so we turned to cannabis.
Chronic pain is prevalent. A 2016 report estimates that over 20% of adults in the United States have experienced some form of chronic pain. Of those 50 million Americans, 8% suffer from some form of high impact chronic pain; pain that has lasted over three months and prohibits them from performing important activities in their daily lives.
People are suffering. Cannabis offers the potential of relief, but cannabis care today leaves much to be desired in the way of guidance, data, and consistency. eo is a digital therapeutic, telemedicine platform and clinical data source. We are on a mission to deliver the future of cannabis care through personalized, calendar-based care plans and ongoing clinical guidance delivered on an intuitive digital platform.
Not all patients are the same. Each person has unique underlying health conditions, personal experiences, and needs. What works for one patient is not guaranteed to work for all. Some patients might be allergic to a specific medication, others might be able to tolerate it but are unable to take it due to incompatible work schedules, and others might be a perfect fit for the same medication.
Last week, you took an edible to help manage your anxiety after a long work day. The cannabis provided some relief, but since then you haven’t been able to recreate that result. Starting your cannabis journey is daunting, and it can be hard to know where to go for guidance.
Proponents of cannabis use in a medical context have often suggested that it is a superior substitute of opioid for chronic pain management. Cannabis owes its analgesic properties to components called cannabinoids, with the two most prominent being cannabidiol (CBD) and tetrahydrocannabinol (THC). Both compounds have similar potential for treating chronic pain, however, while THC is addictive, CBD is not and therefore is of special clinical interest.
Researchers have recently analyzed popular vaping behavior and revealed the advantages of vaporizing medical cannabis. The general advantages of vaporizing medical cannabis include portability, concealability, and efficiency, while the medical advantages like promoting tobacco cessation and it’s quick-acting effects.
Along with THC, the cannabis plant produces over 400 different chemical compounds that include dozens of other cannabinoids like CBD and CBN, and hundreds terpenes like pinene, linalool and myrcene. When the compounds are applied together (whether it’s through smoking, vaping or especially transdermal applications), they work to provide unique effects and benefits.
In the Cannabis Care, Enabled club, eo hosts weekly discussions of medical and wellness cannabis. From our relationships with one another, to novel viruses, to cutting-edge technology; cannabis can effect many areas of our lives. The goal of our audio-only Clubhouse discussions is to foster a community of responsible cannabis users, educators, and advocates on Clubhouse. Visit the link below to join the conversation.
The right community will grant you the ability to talk about shared experiences, educate yourself from a collective pool of knowledge, and bask in the comfort of knowing that you are not alone. There are communities of support for people who are battling cancer and coping with insomnia, so why shouldn’t there be a place for cannabis patients to gather and enjoy the benefits of community?
In honor of Men's Health Month, tonight's webinar will focus on the unique differences that men may have when consuming cannabis.Join Dr. Caplan this evening to review the latest cannabis studies that relate to men's sexual, mental and physical health. All are welcome to attend and share their experiences, or to simply listen and learn.
Cannabidiol (CBD) is a component of the plant cannabis with great potential for medical applications because of its proven anti-inflammatory, anti-tumoral, analgesic (pain-relieving), and anxiolytic (anxiety-relieving) properties and its lack of psychological side effects.
The lack of pain relief combined with the risk of dangerous side effects, including death, has led to a need for alternative options to help treat chronic pain. Recently, there has been growing interest in the possibility that cannabis may be useful in combination or as a substitute for opioids in people with chronic pain.
Recent evidence suggests that using medical cannabis in combination with opioids to treat chronic pain may provide better treatment of pain and allow for a lower dose of opioids. It is important we find other tools that can be used to help improve the treatment of pain while keeping patients safe.
Despite conflicting evidence, for many patients with chronic pain, the risk of using opioids may be greater than the benefits, especially over long periods of time. It is important that patients wishing to understand the potential benefits and risks of using cannabis in addition to opioids discuss this with their health care provider prior to use.
Recent studies have shown patients using cannabis combined with opioids may be able to use a lower opioid dose or stop using opioids while still getting pain relief. This can help improve a patient's quality of life while also reducing the risk of serious side effects or death associated with opioids.
If you are someone using high doses of opioids and not getting adequate pain relief, or you're experiencing unwanted side effects, speaking to your health care provider about a trial of medical cannabis may be an option. Medical cannabis is not right for everyone, just as other medications may not be right for everyone.
Studies have shown low doses of cannabis may allow for lower doses of opioids to be used, leading to reduced side effects, improved symptoms and improved quality of life. Therefore, the combined use of cannabis and opioids may be a viable option for treating chronic pain in some individuals.
Inhaled cannabis can be useful for managing acute symptoms of chronic pain, but it should be vaporized to avoid respiratory harms associated with smoking. Vaporizing cannabis flower is also cheaper than cannabis oils, as dried flower is the cheapest form of product.
We recently discussed a study in which we found smoking cannabis was popular within a sample of medical cannabis dispensary users. We found smoking cannabis was associated with greater cannabis use and preference for THC-dominant chemovars and was associated with concurrent alcohol use disorder. These findings provided several key insights into risks and harm reduction strategies for people smoking cannabis with a medical intent.
This is the first part of a two-part series on a recent examination of the cannabis-use profiles and risk-factors associated with smoking cannabis in people using cannabis with medical intent. Smoking cannabis is associated with exposure to harmful toxins and therefore is one of the greatest health risks related to cannabis use. This is an important consideration for people using cannabis with a medical intent. Therefore, we examined the differences in those who prefer smoking cannabis to other consumption forms for mental health.Â
In dealing with pain, finding and curing the underlying cause is the most effective approach. However, since the cause can be extremely difficult to identify, patients are sometimes left only with the option of managing their pain. For chronic pain sufferers, it is hard to identify a clear path to relief.
Researchers recently identified a signaling pathway in the endocannabinoid system that regulates long-lasting anxiety, a central symptom of post-traumatic stress disorder (PTSD). In particular, CB2 - one of the two main endocannabinoid receptors - mediates the response: its activation appears to have an anxiolytic (anxiety reducing) effect while its inhibition an anxiogenic (anxiety inducing) one.
A recent meta-analysis has found that cannabis is an effective treatment for those dealing with chronic pain. Researchers analyzed studies that compared cannabinoid-based therapies to placebos, concluding that those therapies served as an effective replacement or adjunctive therapy for more common pain relievers, such as opioids.
Get special offers, event invites and the latest on new care offerings and product releases.
